Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
20.9 USD | +1.75% | +1.36% | +45.13% |
May. 02 | Transcript : Kura Oncology, Inc., Q1 2024 Earnings Call, May 02, 2024 | |
May. 02 | Kura Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Business Summary
Number of employees: 142
Managers
Managers | Title | Age | Since |
---|---|---|---|
Troy Wilson
CEO | Chief Executive Officer | 55 | 14-08-21 |
Stephen Dale
CTO | Chief Tech/Sci/R&D Officer | 52 | 20-08-24 |
Kathleen Ford
COO | Chief Operating Officer | 77 | 19-08-08 |
Pete de Spain
IRC | Investor Relations Contact | - | 17-09-30 |
Thomas Doyle
AUD | Comptroller/Controller/Auditor | 53 | 21-05-31 |
Brian Powl
PRN | Corporate Officer/Principal | 50 | 23-08-13 |
Mollie Leoni
PRN | Corporate Officer/Principal | - | 20-01-31 |
Teresa Bair
LAW | General Counsel | 53 | 21-10-17 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Carol Schafer
BRD | Director/Board Member | 60 | 21-06-02 |
Faheem Hasnain
BRD | Director/Board Member | 65 | 15-04-26 |
Thomas Malley
BRD | Director/Board Member | 55 | 15-10-13 |
Mary Szela
BRD | Director/Board Member | 60 | 18-11-05 |
Troy Wilson
CEO | Chief Executive Officer | 55 | 14-08-21 |
Diane Parks
BRD | Director/Board Member | 71 | 19-10-13 |
Helen Collins
BRD | Director/Board Member | 62 | 21-07-28 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 76,180,620 | 73,510,311 ( 96.49 %) | 0 | 96.49 % |
Company contact information
Kura Oncology, Inc.
12730 High Bluff Drive Suite 400
92130, San Diego
+858 500 8800
http://www.kuraoncology.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+45.13% | 1.57B | |
+2.73% | 108B | |
+10.08% | 105B | |
+1.57% | 23.46B | |
-12.05% | 21.72B | |
-7.05% | 18.64B | |
-37.64% | 17.45B | |
-7.28% | 17.19B | |
+6.12% | 13.99B | |
+35.93% | 12.53B |
- Stock Market
- Equities
- KURA Stock
- Company Kura Oncology, Inc.